1. Home
  2. CELU vs BDL Comparison

CELU vs BDL Comparison

Compare CELU & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.67

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$30.00

Market Cap

56.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
CELU
BDL
Founded
2016
1959
Country
United States
United States
Employees
123
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.7M
56.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CELU
BDL
Price
$1.67
$30.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
60.6K
698.0
Earning Date
11-14-2025
12-26-2025
Dividend Yield
N/A
1.86%
EPS Growth
N/A
41.91
EPS
N/A
2.32
Revenue
$40,578,000.00
$201,851,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
$12.91
Revenue Growth
N/A
8.84
52 Week Low
$1.00
$22.61
52 Week High
$4.35
$35.98

Technical Indicators

Market Signals
Indicator
CELU
BDL
Relative Strength Index (RSI) 38.45 46.24
Support Level $1.64 $27.55
Resistance Level $2.01 $30.01
Average True Range (ATR) 0.12 0.10
MACD -0.02 -0.16
Stochastic Oscillator 7.68 46.85

Price Performance

Historical Comparison
CELU
BDL

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: